U.S. Markets open in 42 hrs, 29 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.80 10:05 AM EDT | |
|---|---|---|
| Day High | 0.84 04:00 PM EDT |
|
| Range | 0.04 |
| Volume | 1.04 M | |
|---|---|---|
| 30-Day Avg Vol | 5.71 M |
|
| Difference | -81.67% |
| Market Cap | 190.01 M | |
|---|---|---|
| Mkt Cap Chg | 3.66 M |
| Shares Out | 226.21 M | |
|---|---|---|
| % Shrs Traded | 0.46% | |
| 1yr EPS Est | 0.009 |
| 52-Wk Low | 0.22 11/21/08 | |
|---|---|---|
| 52-Wk High | 1.13 5/28/09 |
|
| Range | 0.91 |
| Prev Close | 0.8238 7/1/09 | |
|---|---|---|
| Today's Open | 0.83 | |
| Change | 0.75% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 496,451.00 |
| Revenue (LFY) | 6.09 M | |
|---|---|---|
| Earnings (LFY) | -23.18 M | |
| Earnings (MRQ) | -3.33 M | |
| Next Earn Est | 0.023 | |
| Next Earnings | 07/14/2009 |
|
| EPS (TTM) | -0.08 | |
| 1yr EPS Growth | 112.86% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 93.00 | |
| PEG Ratio | — | |
| Return on Equity | -119.90 | |
| Beta | 0.61 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Peregrine Pharmaceuticals might only have a few drug candidates in its pipeline, but they're clever ones. It drug candidate Cotara attacks tumors from the inside out: the monoclonal antibody is loaded ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.023 7/14/09 | — — |
—
—
|
| Last Quarter | -0.01 1/31/09 | -0.01 1/31/09 |
0.00
Met
|
| 2 Quarters Ago | -0.02 10/31/08 | -0.02 10/31/08 |
0.00
Met
|
| Quarterly - 01/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 6.83 M | 6.09 M |
| Gross Profit | 2.72 M | 1.29 M |
| Operating Income | -3.23 M | -24.14 M |
| Net Income | -3.33 M | -23.18 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts